Duo Oncology Nominated for Best Startup at 2024 Prix Galien USA Awards.
Duo Oncology is a Prix Galien nominee.
PITTSBURGH (PRWEB) September 16, 2024 – Duo Oncology, a leader in the development of innovative nanomedicine therapy for hard-to-treat cancers, is proud to announce its nomination for "Best Startup" at the 2024 Prix Galien USA Awards. The nomination, one of the highest honors in the life sciences industry, recognizes Duo Oncology’s novel approach to enhance cancer therapy and its commitment to improving patient outcomes through an advanced nanomedicine platform.
The Prix Galien USA Awards, often referred to as the “Nobel Prize of life sciences,” celebrates outstanding achievements in the development of innovative medicines and healthcare technologies. The Prix Galien committee, a global panel of venture capitalists, pharmaceutical executives, and entrepreneurs, nominated 43 companies including 24 pharmaceutical startups this year. Their selection of Duo Oncology for the "Best Startup" category underscores the need for transformation to the foundation of cancer therapy.
"By bringing together brilliant minds and dedicated professionals, we invigorate more research and development, and opportunity for collaboration in the life sciences. This synergy not only accelerates innovation but also brings us closer to even more groundbreaking solutions that can transform patient care, said Bruno Cohen, Chairman of The Galien Foundation. "We look forward to celebrating the power of partnerships and recognizing excellence in innovation with all nominees in November."
“We are honored to be recognized by the Prix Galien Foundation,” said Sam Rothstein, CEO and co-founder of Duo Oncology. “This nomination is a testament to our team’s dedication to innovation in cancer treatment and providing patients with therapies that stop cancer without impinging quality of life.”
As a nominee for the 2024 Prix Galien USA Awards, Duo Oncology stands alongside other industry leaders who are driving innovation and making significant contributions to global health. The winners will be announced at a ceremony on November 7, 2024, in New York City.
